Composition for Inhibiting Replication of Hepatitis B Virus
AssigneeTokyo Metropolitan Institute of Medical Science
InventorsTsubasa Munakata, Michinori Kohara, Takahiro Sanada
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical composition for treating hepatitis B. The present invention provides a composition for inhibiting the replication of hepatitis B virus and a pharmaceutical composition for treating hepatitis B virus infection, each comprising an inhibitory substance against microRNA binding to the 5′ epsilon signal sequence in the pregenomic RNA of hepatitis B virus.
Claims12
A composition for inhibiting the replication of hepatitis B virus, which comprises an inhibitory substance against microRNA binding to the 5′ epsilon signal sequence in the pregenomic RNA of hepatitis B virus.
A pharmaceutical composition for treating hepatitis B virus infection, which comprises an inhibitory substance against microRNA binding to the 5′ epsilon signal sequence in the pregenomic RNA of hepatitis B virus.
Dependencies are inferred from the claim text.